Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer

被引:19
|
作者
Zhang, Liqun [1 ]
Zhang, Jingdong [1 ]
Wang, Yuanhe [1 ]
Dong, Qian [1 ]
Piao, Haiyan [1 ]
Wang, Qiwei [1 ]
Zhou, Yang [1 ]
Ding, Yang [1 ]
机构
[1] China Med Univ, Liaoning Canc Hosp & Inst, Med Oncol Dept Gastrointestinal Tumors, Canc Hosp, 44 Xiaohe Rd, Shenyang 110042, Liaoning, Peoples R China
关键词
chemotherapy response; colorectal cancer; FAR; PGR; prealbumin; prealbumin to globulin; LONG-TERM SURVIVAL; GLOBULIN RATIO; NEUTROPHIL-LYMPHOCYTE; INFLAMMATORY STATUS; PLASMA-FIBRINOGEN; ALBUMIN; PHARMACOKINETICS; RESECTION; IMPACT; TUMORS;
D O I
10.1002/jcla.22958
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives The purpose of this study was to explore whether pretreatment potential prognostic factors are related to chemotherapeutic outcomes and the prognosis of inpatients with metastatic colorectal cancer (mCRC) undergoing chemotherapy. Materials and methods Data from 71 patients with mCRC were analyzed retrospectively. The relationship between the potential prognostic factors before first-line chemotherapy and the clinicopathological characteristics and chemotherapy response of the patients was calculated using Fisher's exact test and the chi-square test. The prognostic factors were analyzed using univariate and multivariate analyses. We analyzed the subgroups using the Mann-Whitney U test. Results Four factors were eventually used as prognostic factors, namely the albumin-to-globulin ratio (AGR), the fibrinogen-to-albumin ratio (FAR), the prealbumin-to-globulin ratio (PGR), and the fibrinogen-to-prealbumin ratio (FPR); the cutoff values of the four potential prognostic factors were 1.40, 10.63, 5.44, and 18.49, respectively. The high AGR and PGR groups had a higher response rate than that of the low groups. Patients in the low FAR and FPR groups showed a higher objective response rate than the high FAR and FPR groups. Patients with low FPR were associated with a higher disease control rate than patients with high FPR. Higher progression-free survival (PFS) was observed in the high AGR and PGR and low FAR and FPR groups. The AGR, FAR, PGR, and FPR were considered reliable prognostic factors for PFS in a univariate analysis. Conclusions The prechemotherapy AGR, FAR, PGR, and FPR were good prognostic factors to predict the chemotherapy response and PFS in patients with mCRC.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience
    Gossling, Gustavo C. L.
    Chedid, Marcio F.
    Pereira, Fernando S.
    da Silva, Rafaela K.
    Andrade, Leonardo B.
    Peruzzo, Nicolas
    Saueressig, Mauricio G.
    Schwartsmann, Gilberto
    Parikh, Aparna R.
    ONCOLOGIST, 2021, 26 (09): : E1581 - E1588
  • [22] A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis
    Li, Shuyuan
    Chen, Shuo
    Wang, Boxue
    Zhang, Lin
    Su, Yinan
    Zhang, Xipeng
    FRONTIERS IN MEDICINE, 2020, 7
  • [23] Prognostic Inflammatory Index Based on Preoperative Peripheral Blood for Predicting the Prognosis of Colorectal Cancer Patients
    Fu, Jinming
    Zhu, Ji
    Du, Fenqi
    Zhang, Lijie
    Li, Dapeng
    Huang, Hao
    Tian, Tian
    Liu, Yupeng
    Zhang, Lei
    Liu, Ying
    Zhang, Yuanyuan
    Xu, Jing
    Meng, Shuhan
    Jia, Chenyang
    Sun, Simin
    Li, Xue
    Zhao, Liyuan
    Zhang, Ding
    Kang, Lixin
    Gao, Lijing
    Zheng, Ting
    Cai, Sanjun
    Liu, Yanlong
    Zhao, Yashuang
    CANCERS, 2021, 13 (01) : 1 - 21
  • [24] Prognostic factors predicting survival of metastatic breast cancer patients: analysis of 591 patients.
    Kim, SI
    Jung, SY
    Sohn, JH
    Keum, KC
    Park, BW
    Lee, KS
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S142 - S142
  • [25] PROGNOSTIC FACTORS PREDICTING SURVIVAL AFTER FIRST RECURRENCE IN PATIENTS WITH METASTATIC BREAST CANCER
    Hikichi, Masahiro
    Itou, Yuki
    Kiriyama, Yuka
    Miyajima, Shinsuke
    Kobayashi, Naomi
    Urano, Makoto
    Kuroda, Makoto
    Utsumi, Toshiaki
    BREAST, 2013, 22 : S49 - S49
  • [26] Clinical prognostic factors of survival in patients with combined chemotherapy for metastatic colorectal cancer (MCRC)
    Reina, Juan J.
    Fernandez, Eva
    Rodriguez, Alberto
    Lopez-Ladron, Amalia
    Bayo, Juan L.
    Vincente, David
    Salvador, Javier
    Fuentes, Jose
    Calderon, Ana
    Montano, Alvaro
    ANNALS OF ONCOLOGY, 2004, 15 : 99 - 100
  • [27] Prognostic factors of patients (pts) with salvage-line metastatic colorectal cancer (mCRC)
    Bando, Hideaki
    Oki, Eiji
    Takeda, Yuriko
    Misumi, Toshihiro
    Suzuki, Motoko
    Wakabayashi, Masashi
    Yamazaki, Kentaro
    Grothey, Axel
    Mayer, Robert J.
    Li, Jin
    Andre, Thierry
    Shi, Qian
    De Gramont, Aimery
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 115 - 115
  • [28] Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases
    Jang, Ki Ung
    Kim, Chan Wook
    Kim, Ki-Hun
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Tae Won
    Kim, Pyo Nyun
    Kim, Jong Hoon
    Kim, Jin Cheon
    ANNALS OF COLOPROCTOLOGY, 2016, 32 (03) : 92 - 100
  • [29] Prognostic value of biomarkers in metastatic colorectal cancer patients
    Kataoka, Kozo
    Kanazawa, Akiyoshi
    Nakajima, Akio
    Yamaguchi, Ayane
    Arimoto, Akira
    JOURNAL OF SURGICAL RESEARCH, 2015, 194 (02) : 343 - 350
  • [30] Predictive and prognostic factors of apatinib in metastatic colorectal cancer.
    Wang, Fen
    Wang, Shubin
    Yuan, Xia
    Jia, Jun
    Bi, Xiaoxia
    Zhou, Zeqiang
    Zhou, Qiming
    Li, Xia
    Luo, Changguo
    Deng, Minghui
    Yi, Liangjie
    Li, Yong
    Lu, Jianxin
    Su, Wenzhi
    Chen, Hanbin
    Zhu, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)